Prostaglandin E2 regulates aromatase activity and expression in human adipose stromal cells via two distinct receptor subtypes.
about
Mechanisms underlying the growth inhibitory effects of the cyclo-oxygenase-2 inhibitor celecoxib in human breast cancer cellsExploration of prostanoid receptor subtype regulating estradiol and prostaglandin E2 induction of spinophilin in developing preoptic area neuronsMechanical phenotype is important for stromal aromatase expression.Isolation and Characterization of Aromatase Inhibitors from Brassaiopsis glomerulata (Araliaceae).Estrogen receptor-related receptor alpha mediates up-regulation of aromatase expression by prostaglandin E2 in prostate stromal cellsProstaglandin E receptor EP1 suppresses breast cancer metastasis and is linked to survival differences and cancer disparities.Growth factor signaling enhances aromatase activity of breast cancer cells via post-transcriptional mechanisms.The role of n-3 polyunsaturated fatty acids in the prevention and treatment of breast cancerCystic duct dilatations and proliferative epithelial lesions in mouse mammary glands upon keratin 5 promoter-driven overexpression of cyclooxygenase-2.The EP1 receptor for prostaglandin E2 promotes the development and progression of malignant murine skin tumorsRole of prostaglandin E2-dependent angiogenic switch in cyclooxygenase 2-induced breast cancer progression.Putative role of prostaglandin receptor in intracerebral hemorrhage.Function of PPARgamma and its ligands in lung cancer.Update on the use of aromatase inhibitors in breast cancer.Aromatase and COX in breast cancer: enzyme inhibitors and beyondSuppression of aromatase in human breast cells by a cyclooxygenase-2 inhibitor and its analog involves multiple mechanisms independent of cyclooxygenase-2 inhibition.Prostaglandin E2 EP receptors as therapeutic targets in breast cancer.HIF-1α stimulates aromatase expression driven by prostaglandin E2 in breast adipose stroma.Xanthones from the botanical dietary supplement mangosteen (Garcinia mangostana) with aromatase inhibitory activityAntagonism of the prostaglandin E receptor EP4 inhibits metastasis and enhances NK functionEP(3) prostanoid receptor isoforms utilize distinct mechanisms to regulate ERK 1/2 activationInhibition of cyclooxygenase-2 down-regulates aromatase activity and decreases proliferation of Leydig tumor cellsRegulation of adipose oestrogen output by mechanical stress.Cyclooxygenase inhibitors: scope of their use and development in cancer chemotherapy.Cancer prevention and treatment using combination therapy with plant- and animal-derived compounds.Impact of obesity on mammary gland inflammation and local estrogen production.Association between cyclooxygenase-2 expression in atypical hyperplasia and risk of breast cancer.Central Administration of Indomethacin Mitigates the Injury-Induced Upregulation of Aromatase Expression and Estradiol Content in the Zebra Finch Brain.Bioactivity screening and mass spectrometric confirmation for the detection of PPARδ agonists that increase type 1 muscle fibres.EP2 and EP4 receptors regulate aromatase expression in human adipocytes and breast cancer cells. Evidence of a BRCA1 and p300 exchange.Abnormal Expression of Prostaglandins E2 and F2α Receptors and Transporters in Patients with Endometriosis.Reciprocal interactions between prostaglandin E2- and estradiol-dependent signaling pathways in the injured zebra finch brain.Macronutrient intakes and serum oestrogen, and interaction with polymorphisms in CYP19A1 and HSD17B1 genes: a cross-sectional study in postmenopausal Japanese women.Prostaglandin E2 receptor EP1 in healthy and diseased human endometrium.Prostaglandin receptor EP3 regulates cell proliferation and migration with impact on survival of endometrial cancer patients.Relations of omega-3 and omega-6 intake with mammographic breast density.
P2860
Q24810540-B81170B2-A485-4FEA-B6F1-46D1D173F434Q28584236-110D2C97-307E-43B8-84CD-8AF853B78577Q30426266-81C1A309-1BB7-4CF8-A20F-8DA42B4B4527Q33531689-C729A9E4-240F-4C45-A85E-AFBE9729EB97Q33637491-1719BD45-DC63-4A87-A0D8-914C60B1C2E0Q34279863-F5F5428E-6FB7-4D35-96B7-BCA93002638BQ34538422-F0224E60-043B-4B38-BFFC-4B0DC42D4AACQ34578129-247DB56D-4BDD-4151-966B-92A032D3F813Q35083639-FDCBE6C8-F23A-47DB-A4C9-6A4EFE1D1EEAQ35722400-62A511BF-0FAC-461A-A379-9A5C3590D45EQ35735316-7E75C6BC-3A25-4952-AA41-C10F83D2960DQ36337569-41D0A622-CE9C-4298-92E6-35793953F902Q36414175-BB93CC79-8DAA-45CB-903A-4BE9212E1B9EQ36613881-2695B50A-9988-4E1D-9400-79DFCDD0F78AQ36802779-6CF4D0DD-9F26-4B92-A708-1E2D101AF424Q36802784-8C79439C-4536-4ADF-8EEB-436005107892Q36806255-03CD5BB6-FD9B-4EAA-A574-EBA958D53FCAQ36903378-BDD1B038-6260-4544-AE4F-394DF9CB1012Q36948035-89555913-7914-4031-8294-CAB46F1322B8Q37082097-FF20A9D8-E945-4F95-9BDA-8C27BB4D3141Q37186148-A3DC1DD0-BF2A-41FB-98EB-EEE46EFFB122Q37431170-9E900315-7063-4372-9C37-287860A2B7B9Q37578879-9EE8478B-FDF3-454F-9926-F4F73A35403BQ37646513-ABF76D07-9C00-410F-9DC1-035E073DE31BQ38066962-49D937C2-D6C1-4DA7-B0FB-12452BF53769Q38220763-C1AFD1C3-3108-4CFD-9C5C-0455C2C0B923Q38427421-5BB400B9-0E36-4B32-AE9D-5BE4BC41472EQ38748506-3A568C68-0049-43D6-B95C-A639CD84739BQ39052463-21246A5A-8DF7-4EFD-AFD0-8427AE9B17ADQ40034911-9ABF8360-CC5F-4D17-8B01-22EDE2AA9CA2Q42380795-A53D41B3-9748-4BD8-A06E-A5F5596671F5Q47130847-59A79AA3-357E-4AB7-850A-3542BC490051Q47693758-DA65F4FA-8841-4724-8575-2E87CC34D249Q48310988-C9172AF0-C33E-4182-A5D8-7B00D110467CQ50128233-94C1D2FF-CD5C-4AD7-81AD-97E22E99DE02Q51760105-62DA7F4F-2597-4733-955B-5CBD2DA4BF34
P2860
Prostaglandin E2 regulates aromatase activity and expression in human adipose stromal cells via two distinct receptor subtypes.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Prostaglandin E2 regulates aro ...... wo distinct receptor subtypes.
@ast
Prostaglandin E2 regulates aro ...... wo distinct receptor subtypes.
@en
Prostaglandin E2 regulates aro ...... wo distinct receptor subtypes.
@nl
type
label
Prostaglandin E2 regulates aro ...... wo distinct receptor subtypes.
@ast
Prostaglandin E2 regulates aro ...... wo distinct receptor subtypes.
@en
Prostaglandin E2 regulates aro ...... wo distinct receptor subtypes.
@nl
prefLabel
Prostaglandin E2 regulates aro ...... wo distinct receptor subtypes.
@ast
Prostaglandin E2 regulates aro ...... wo distinct receptor subtypes.
@en
Prostaglandin E2 regulates aro ...... wo distinct receptor subtypes.
@nl
P356
P1476
Prostaglandin E2 regulates aro ...... wo distinct receptor subtypes.
@en
P2093
Jeanette A Richards
Robert W Brueggemeier
P304
P356
10.1210/JC.2002-021475
P407
P577
2003-06-01T00:00:00Z